Viking Therapeutics (VKTX) Stock Chart & Stock Price History $29.20 -4.87 (-14.29%) Closing price 04:00 PM EasternExtended Trading$29.37 +0.17 (+0.57%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Viking Therapeutics Stock Price Performance 5 Day Performance-9.57%1 Month Performance-15.36%3 Month Performance-44.48%6 Month Performance-54.82%Year-To-Date Performance-27.44%1 Year Performance-21.97% Receive VKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address VKTX Stock Chart for Monday, February, 24, 2025 VKTX Chart by TradingView Viking Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/24/2025$34.07$29.20-14.29%$34.11$29.018.92 million shs$3.25 billion02/21/2025$31.63$34.07+7.71%$36.39$31.5015.69 million shs$3.80 billion02/20/2025$32.29$31.63-2.04%$33.24$31.134.72 million shs$3.52 billion02/19/2025$29.26$32.29+10.36%$34.37$28.908.64 million shs$3.60 billion02/18/2025$30.48$29.26-4.00%$30.70$29.252.46 million shs$3.26 billion02/17/2025$30.48$30.48$30.88$29.503.28 million shs$3.40 billion02/14/2025$29.50$30.48+3.32%$30.88$29.503.28 million shs$3.40 billion02/13/2025$29.32$29.50+0.61%$30.12$28.643.66 million shs$3.29 billion02/12/2025$29.96$29.32-2.14%$30.30$29.162.70 million shs$3.27 billion02/11/2025$30.17$29.96-0.70%$29.99$29.084.68 million shs$3.34 billion Get the Latest News and Ratings for VKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/10/2025$32.56$30.17-7.34%$32.74$29.915.40 million shs$3.36 billion02/07/2025$31.46$32.56+3.50%$32.88$30.804.82 million shs$3.63 billion02/06/2025$33.50$31.46-6.09%$33.40$29.909.33 million shs$3.51 billion02/05/2025$32.37$33.50+3.49%$33.90$32.374.81 million shs$3.73 billion02/04/2025$31.52$32.37+2.70%$34.07$30.906.36 million shs$3.61 billion02/03/2025$32.75$31.52-3.76%$32.40$31.133.92 million shs$3.51 billion01/31/2025$33.69$32.75-2.79%$34.78$32.284.00 million shs$3.65 billion01/30/2025$33.43$33.69+0.78%$34.29$33.302.47 million shs$3.75 billion01/29/2025$34.32$33.43-2.59%$34.60$33.171.64 million shs$3.73 billion01/28/2025$33.46$34.32+2.57%$34.74$32.772.35 million shs$3.82 billion01/27/2025$34.50$33.46-3.01%$34.68$32.902.74 million shs$3.73 billion01/24/2025$34.94$34.50-1.26%$35.97$34.193.46 million shs$3.84 billion01/23/2025$34.05$34.94+2.61%$35.11$32.523.99 million shs$3.89 billion Related Companies Viatris Stock Chart Moderna Stock Chart Dr. Reddy's Laboratories Stock Chart Vaxcyte Stock Chart Sarepta Therapeutics Stock Chart Qiagen Stock Chart Ascendis Pharma A/S Stock Chart Roivant Sciences Stock Chart Revolution Medicines Stock Chart Legend Biotech Stock Chart Receive VKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VKTX) was last updated on 2/24/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free vktx Stock Alerts